Canonical ingredient

Morphinan-6-one, 4,5-epoxy-3-hydroxy-17-methyl-, hydrochloride, (5?)-

HYDROMORPHONE HYDROCHLORIDE

86 linked products

Official identifiers

CAS 71-68-1 ChEBI CHEBI:5791 InChI InChI=1S/C17H19NO3.ClH/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18;/h2,4,10-11,16,19H,3,5-8H2,1H3;1H/t10-,11+,16-,17-;/m0./s1 InChIKey XHILEZUETWRSHC-NRGUFEMZSA-N SMILES [Cl-].[H+].[H][C@@]12CCC(=O)[C@@H]3Oc4c(O)ccc5c4[C@@]31CCN(C)[C@@H]2C5

Names and synonyms

Morphinan-6-one, 4,5-epoxy-3-hydroxy-17-methyl-, hydrochloride, (5?)- (en)
hydromorphone hydrochloride (en)
Chlorhydrate d'hydromorphone (fr)
Chlorhydrate de 4,5?-époxy-3-hydroxy-17-méthylmorphinan-6-one (fr-CA)

Source-scoped chemical properties

Every value keeps its own authority, licence and retrieval date. Conflicting values are not silently merged.

canada dsl listing: listed; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl bioaccumulative: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl inherently toxic aquatic: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl meets cepa categorization: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl meets environmental: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl meets human health: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl persistent: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl substance category: Organics; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03

Safety and technical documents

General references and manufacturer-specific SDS documents are kept separate.

0 document(s)

No verified SDS or technical sheet is linked yet. This absence is explicit and does not mean that no document exists.

End-to-end traceability

Only links supported by an identified source are published. Missing evidence remains explicitly unknown.

Partial chain

Evidence still missing

Country or region of origin
Raw-material producer
Ingredient manufacturer
Distributor
Transformation steps

Documented origins

No origin has been proven yet by an explicit source.

Documented organizations

No organization has been proven yet by an explicit source.

Documented transformations

No transformation step has been proven yet by an explicit source.

Method: a company’s registration country is never used as evidence of a material’s origin.

Products containing this ingredient

APO-HYDROMORPHONE

APO-HYDROMORPHONE

APO-HYDROMORPHONE

APO-HYDROMORPHONE

APO-HYDROMORPHONE CR

APO-HYDROMORPHONE CR

APO-HYDROMORPHONE CR

APO-HYDROMORPHONE CR

APO-HYDROMORPHONE CR

APO-HYDROMORPHONE CR

APO-HYDROMORPHONE CR

APO-HYDROMORPHONE CR

BAR-HYDROMORPHONE CR

BAR-HYDROMORPHONE CR

BAR-HYDROMORPHONE CR

BAR-HYDROMORPHONE CR

BAR-HYDROMORPHONE CR

BAR-HYDROMORPHONE CR

BAR-HYDROMORPHONE CR

BAR-HYDROMORPHONE CR

250 · MG · VIAL

DILAUDID-HP-PLUS

HYDROMORPH CONTIN

HYDROMORPH CONTIN

HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 12MG

HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 18MG

HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 24MG

HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 30MG

HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG

HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 6MG

HYDROMORPH.IR - 2MG

HYDROMORPH.IR - 4MG

HYDROMORPH.IR - 8MG

HYDROMORPHONE HCL TAB 2MG USP

HYDROMORPHONE HCL TAB 4MG USP